Bringing the fundamentals into focus…
Back to Pacific Biosciences of California, Inc.
How Pacific Biosciences of California, Inc. stacks up
PACB · against 1,335 other Healthcare companies
Profitability
19/ 100
Near the bottom of its peers.
Ranked #1,076 of 1,336 · scores higher than 19% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 10–19, including PACB · Click a bar to see the companies
Why profitability scores 19?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 86% of peers. Operating margin: -83.5% vs peer median 7.1%
- a lower return on invested capital: weaker than 84% of peers. Return on invested capital: -32.8% vs peer median 4.7%
- a lower return on assets: weaker than 79% of peers. Return on assets: -17.5% vs peer median 1.7%
Metric by metric
Position: dot = PACB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -32.8% | 4.7% | 16% | 33% | |
| Operating marginHigher is better · 1,251 reported | -83.5% | 7.1% | 14% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -17.5% | 1.7% | 21% | 33% | |
| Return on equityHigher is better · 1,252 reported | -929.3% | 3.2% | 1% | Context only | |
| Gross marginHigher is better · 1,394 reported | 29.4% | 45.9% | 33% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around PACB| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,076 | 647M USD | 19 | 40 | |
| 1,076 | 441M USD | 19 | 34 | |
| 1,076 | 1.5B USD | 19 | 32 | |
| 1,076 | 25M GBP (≈$33M) | 19 | 31 | |
| 1,076 | 758M USD | 19 | 35 | |
| 1,076 | 1.2B USD | 19 | 40 | |
| 1,076 | 522M USD | 19 | 12 | |
| 1,076 | 97M USD | 19 | 63 | |
| 1,090 | 2.21T KRW (≈$1.6B) | 18 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score